RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness

被引：0
|
作者：
Yafeng Liu
Tao Han
Rui Miao
Jiawei Zhou
Jianqiang Guo
Zhi Xu
Yingru Xing
Ying Bai
Jing Wu
Dong Hu
机构：
[1] Anhui University of Science and Technology,School of Medicine
[2] Anhui University of Science and Technology,Anhui Province Engineering Laboratory of Occupational Health and Safety
[3] Anhui University of Science and Technology,Key Laboratory of Industrial Dust Prevention and Control & Occupational Safety and Health of the Ministry of Education
[4] Anhui Zhongke Gengjiu Hospital,Department of Clinical Laboratory
来源：
BMC Cancer | / 24卷
关键词：
LUAD; RACGAP1; Cell cycle; Tumor stemness; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway
    Zhai, Kui
    Jiang, Ni
    Wen, Ji-Fan
    Zhang, Xiao
    Liu, Tao
    Long, Kai-Jun
    Ke, Xi-Xian
    Xu, Gang
    Chen, Cheng
    JOURNAL OF THORACIC DISEASE, 2023, 15 (05) : 2644 - 2658
  • [22] CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis
    Zhou, Xuefeng
    Cheng, Zhenshun
    Chen, Hao
    Shi, Shenqi
    Wang, Xianguo
    Orang, Matthew
    Zhao, Jinping
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (12) : 10186 - 10194
  • [23] High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
    Hoda, Mir Alireza
    Rozsas, Anita
    Lang, Elisabeth
    Klikovits, Thomas
    Lohinai, Zoltan
    Torok, Szilvia
    Berta, Judit
    Bendek, Matyas
    Berger, Walter
    Hegedus, Balazs
    Klepetko, Walter
    Renyi-Vamos, Ferenc
    Grusch, Michael
    Dome, Balazs
    Laszlo, Viktoria
    ONCOTARGET, 2016, 7 (12) : 13388 - 13399
  • [24] ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma
    Miyashita, Naoya
    Horie, Masafumi
    Mikami, Yu
    Urushiyama, Hirokazu
    Fukuda, Kensuke
    Miyakawa, Kazuko
    Matsuzaki, Hirotaka
    Makita, Kosuke
    Morishita, Yasuyuki
    Harada, Hiroaki
    Backman, Max
    Lindskog, Cecilia
    Brunnstrom, Hans
    Micke, Patrick
    Nagase, Takahide
    Saito, Akira
    CANCER LETTERS, 2020, 489 : 121 - 132
  • [25] Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma
    Shi, Run
    Sun, Qi
    Sun, Jing
    Wang, Xin
    Xia, Wenjie
    Dong, Gaochao
    Wang, Anpeng
    Jiang, Feng
    Xu, Lin
    TUMOR BIOLOGY, 2017, 39 (03)
  • [26] OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma
    Weng, Weiwei
    Zhang, Qiongyan
    Xu, Midie
    Wu, Yong
    Zhang, Meng
    Shen, Chen
    Chen, Xiaochen
    Wang, Yiqin
    Sheng, Weiqi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (05): : 2234 - 2244
  • [27] Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis
    Chen, Liangyuan
    Cao, Pengju
    Wu, Qiumei
    Guo, Yiqing
    Yang, Yang
    Chen, Falin
    CLINICAL LABORATORY, 2019, 65 (03) : 305 - 312
  • [28] Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma
    Xue, Min
    Tao, Weimin
    ONCOLOGY REPORTS, 2017, 38 (05) : 2637 - 2646
  • [29] VCAN promotes clear cell renal cell carcinoma tumor progression and metastasis, and predicts poor prognosis
    Mitsui, Yozo
    Kato, Taku
    Maekawa, Shigekatsu
    Hashimoto, Yutaka
    Shiina, Marisa
    Sumida, Mitsuho Imai
    Wong, Ryan Kenji
    Yamamura, Soichiro
    Shahryari, Varahram
    Majid, Shahana
    Saini, Sharanjot
    Deng, Guoren
    Dahiya, Rajvir
    Nakajima, Koichi
    Tanaka, Yuichiro
    CANCER RESEARCH, 2017, 77
  • [30] Overexpression of P4HA1 associates with poor prognosis and promotes cell proliferation and metastasis of lung adenocarcinoma
    Ning, Yue
    Zheng, Hongmei
    Zhan, Yuting
    Liu, Sile
    Yang, Yang
    Zang, Hongjing
    Wen, Qiuyuan
    Zhang, Yajie
    Fan, Songqing
    JOURNAL OF CANCER, 2021, 12 (22): : 6685 - 6694
12345